Release Date: 19/05/16 09:36 Summary: 2016 Chairman's Address to Shareholders-PSA.AX Price Sensitive: No Download Document 47.02KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%